US 12,283,361 B2
Methods and devices for burden-free blood glucose management with minimal user interaction
Lane Desborough, Thousand Oaks, CA (US)
Assigned to NUDGE BG, INC., Thousand Oaks, CA (US)
Filed by Nudge BG, Inc., Thousand Oaks, CA (US)
Filed on May 4, 2022, as Appl. No. 17/736,813.
Application 17/736,813 is a continuation of application No. 17/403,518, filed on Aug. 16, 2021, granted, now 11,942,202.
Application 17/403,518 is a continuation of application No. 17/149,598, filed on Jan. 14, 2021, granted, now 11,101,030, issued on Aug. 24, 2021.
Claims priority of provisional application 62/962,178, filed on Jan. 16, 2020.
Claims priority of provisional application 62/962,179, filed on Jan. 16, 2020.
Prior Publication US 2022/0262478 A1, Aug. 18, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 20/17 (2018.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G05B 23/02 (2006.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01)
CPC G16H 20/17 (2018.01) [A61M 5/14248 (2013.01); A61M 5/1723 (2013.01); G05B 23/0272 (2013.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); A61M 2205/18 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2230/201 (2013.01)] 27 Claims
OG exemplary drawing
 
1. A method comprising:
receiving previous insulin delivery data at a user device from an insulin pump;
receiving at the user device estimated glucose data from a continuous glucose monitor; and
determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data;
communicating instructions to an insulin pump to deliver the insulin delivery amount;
not providing data representative of the estimated glucose data or the insulin delivery data to a user through a user interface of the user device.